EKF Diagnostics Holdings PLC Result of AGM (9062X)
May 02 2019 - 6:21AM
UK Regulatory
TIDMEKF
RNS Number : 9062X
EKF Diagnostics Holdings PLC
02 May 2019
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Result of AGM
EKF Diagnostics Holdings (AIM: EKF), the AIM quoted
point-of-care business, announces that at the Annual General
Meeting held earlier today, all resolutions were duly passed.
Enquiries:
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Aubrey Powell / Lauren Kettle / George Tzimas
(Corporate Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus/ Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is a leading point-of-care diagnostics and central
laboratory assay manufacturer with an estimated 80,000 hemoglobin,
hematocrit, HbA1c, glucose and lactate analyzers in regular use
across more than 100 countries. EKF specializes in developing tests
for use in anemia and diabetes diagnosis and management, as well as
providing a portfolio of reagents for use in clinical chemistry
analyzers.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGSSAFSEFUSEFI
(END) Dow Jones Newswires
May 02, 2019 06:21 ET (10:21 GMT)
EKF Diagnostics (AQSE:EKF.GB)
Historical Stock Chart
From Sep 2024 to Oct 2024
EKF Diagnostics (AQSE:EKF.GB)
Historical Stock Chart
From Oct 2023 to Oct 2024